Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 3701–3750 of 33040
On March 6, 2025, each of Peter Coleman, Paul Graves, Alan Fitzpatrick, Christina Lampe-Önnerud, Fernando Oris de Roa, Florencia Heredia, John Turner, Leanne Heywood, Michael Barry, Pablo Marcet, Robert Pallash and Steven Merkt ceased to be a director (and removed from all committees thereof, as applicable) of the Company, effective as of the Effective Time.
On March 5, 2025, the Company made an internal announcement that Gilberto Antoniazzi, Vice President, Chief Financial Officer and Treasurer, will be leaving the Company after helping with the transition related to the Transaction, and that Sara Ponessa, Vice President, General Counsel and Secretary, will also be leaving the Company.
On March 5, 2025, the Company made an internal announcement that Gilberto Antoniazzi, Vice President, Chief Financial Officer and Treasurer, will be leaving the Company after helping with the transition related to the Transaction, and that Sara Ponessa, Vice President, General Counsel and Secretary, will also be leaving the Company.
On March 6, 2025, each of Peter Coleman, Paul Graves, Alan Fitzpatrick, Christina Lampe-Önnerud, Fernando Oris de Roa, Florencia Heredia, John Turner, Leanne Heywood, Michael Barry, Pablo Marcet, Robert Pallash and Steven Merkt ceased to be a director (and removed from all committees thereof, as applicable) of the Company, effective as of the Effective Time.
On February 11, 2025, Red Robin Gourmet Burgers, Inc. (the “Company”) announced the departure of Kevin Mayer, the Company’s Chief Marketing Officer (the “Executive”), effective February 11, 2025.
On March 4, 2025, Samuel M. Gullo, a member of the Board of Directors (the “Board”) of Financial Institutions, Inc. (the “Company”) and the Board of Directors of the Company’s wholly-owned subsidiary, Five Star Bank, informed the Board of his decision not to stand for re-election at the 2025 Annual Meeting of Shareholders.
the passing of Patrick Connelly
On February 28, 2025, Erica Schultz informed Confluent, Inc. (“Confluent”) of her intent to retire as Confluent’s President of Field Operations.
On February 28, 2025, Erica Schultz informed Confluent, Inc. (“Confluent”) of her intent to retire as Confluent’s President of Field Operations.
Neil G. Budnick, a Class I director on the board of directors (the “Board”) of Information Services Group, Inc. (the “Company”), notified the Company of his intent to retire as a Class I director, effective as of March 14, 2025.
On March 5, 2025, Zheqing (Simon) Shen informed Nu Skin Enterprises, Inc. (the “Company”) that he has decided not to stand for re-election to the Company’s Board of Directors (the “Board”) at the Company’s 2025 Annual Meeting of Stockholders due to other professional commitments.
On March 3, 2025, the Board approved the transition and resignation of Frank Martell, the Company’s President and Chief Executive Officer (“CEO”).
On March 5, 2025, Richard J. Burns notified Teradyne, Inc. (the “Company”) of his decision to retire as President, Semiconductor Test of the Company effective June 1, 2025.
Mr. Keith J. Allman is retiring from his position as the Company’s President and Chief Executive Officer effective as of July 6, 2025.
Mr. Harry Rashwan, who was serving as Chief Executive Officer of the Sponsor, stepped down from such role to take on a new leadership role within 21co and was succeeded by Mr. Russell Barlow as Chief Executive Officer of the Sponsor;
Ms. Ophelia Snyder, who was serving as President and Chief Financial Officer of the Sponsor, stepped down from such roles to take on a new leadership role within 21co and was succeeded in her role as President of the Sponsor by Mr. Duncan Moir;
Ms. Ophelia Snyder, who was serving as President and Chief Financial Officer of the Sponsor, stepped down from such roles to take on a new leadership role within 21co and was succeeded in her role as President of the Sponsor by Mr. Duncan Moir;
Ms. Ophelia Snyder, who was serving as President and Chief Financial Officer of the Sponsor, stepped down from such roles to take on a new leadership role within 21co and was succeeded in her role as President of the Sponsor by Mr. Duncan Moir;
Mr. Harry Rashwan, who was serving as Chief Executive Officer of the Sponsor, stepped down from such role to take on a new leadership role within 21co and was succeeded by Mr. Russell Barlow as Chief Executive Officer of the Sponsor;
On March 3, 2025, Aw Jeen Rong resigned from his position as Executive Director of Graphjet Technology (the “Company”), effective immediately.
On February 28, 2025, Richard Pilnik, who has been a member of the Board of Directors (the “Board”) of DiaMedica Therapeutics Inc. (the “Company”), for over 15 years, informed the Company of his decision to retire and not to stand for re-election at the Company’s 2025 Annual General Meeting of Shareholders (the “AGM”).
On March 3, 2025, Ronald P. Trout, an independent member of the Board of Managers (the “Board”) of Dorchester Minerals Management GP LLC (“DMMGP”), the general partner of Dorchester Minerals Management LP (together with DMMGP, the “General Partners”), the general partner of Dorchester Minerals, L.P. (the “Company”), informed the Board of his decision to retire from the Board at the end of his current term and not stand for re-election as a manager at the Company’s 2025 Annual Meeting of Limited Partners (the “2025 Annual Meeting”).
Mr. Norton will succeed Timothy Canning, who served as the Company’s Chief Executive Officer since January 18, 2024, and who is resigning from his position, effective as of the Effective Date.
On March 4, 2025, Christopher W. Degnan notified Snowflake Inc. (the “ Company ”) of his intention to step down as the Company’s Chief Revenue Officer.
On March 3, 2025, Lara Caimi informed the Company of her intention to step down from her position as President of Worldwide Field Operations, effective March 3, 2025.
The elimination of this position constitutes a termination without cause, effective February 28, 2025, under Ms. Feldman’s Employment Agreement with the Company.
Jeffrey A. Davis will continue in his current role as Chief Financial Officer through the filing of the Company’s Annual Report on Form 10-K for the fiscal year ended February 1, 2025 and until Mr. Glendinning assumes the role.
On February 28, 2025, Roger Fradin notified the Company of his decision to resign as a director of the Board, effective immediately.
On March 4, 2025, Tomas Kiselak, a member of the Board of Directors (the “Board) of Dianthus Therapeutics, Inc. (the “Company”), notified the Company of his resignation from the Board effective as of the close of business on March 4, 2025.
On March 3, 2025, Peter Benz, a member of the Board of Directors (the “Board”) of Red Violet, Inc. (the “Company”) resigned effective March 4, 2025 from the Board and its committees to pursue other business commitments.
the Company’s President and Chief Scientific Officer position will be eliminated effective in April 2025
the date of Leonardo Basola's resignation as Chief Financial Officer of the Company
On the Exchange Effective Date, Paul Weibel notified the Company of his resignation from the Board of Directors of the Company (the “Board”), effective on such date.
Ms. Phipps succeeds Jim Mattingly, whose transition and departure was not a result of any disagreement with the Company or any matter relating to the Company’s operations, policies or practices.
Mr. Goel will leave the Company effective March 31, 2025
resignations of Pierangelo Negri as a director
On March 3, 2025, Phillip A. Sharp, Ph.D. informed the Board of Directors (the “Board”) of Alnylam Pharmaceuticals, Inc. (the “Company”) of his retirement from the Board, effective as of May 8, 2025.
On March 4, 2025, John Krenicki Jr. informed the Board of Directors (the “Board”) of Devon Energy Corporation (“Devon”) of his decision to retire from the Board at the end of his current term and not stand for re-election as a director at Devon’s 2025 annual meeting of stockholders (the “Annual Meeting”).
On March 5, 2025, GBLI announced that Stephen W. Ries, SVP, Senior Counsel & Head of Investor Relations, has stepped down from his position, effective February 28, 2025.
On March 4, 2025, Travis Whitfill notified the Board of Directors (the “Board”) of IN8bio, Inc. (the “Company”) of his resignation from the Board and its committees, effective as of May 9, 2025.
On March 5, 2025, General Mills, Inc. (the “Company”) announced that Jonathan J. Nudi, Group President, North America Pet, International, and North America Foodservice, will retire from the Company effective June 30, 2025.
on February 28, 2025, Ernie L. Danner, Curtis F. Harrell and Andrew L. Waite resigned as directors, effective as of the end of such date
on February 28, 2025, Ernie L. Danner, Curtis F. Harrell and Andrew L. Waite resigned as directors, effective as of the end of such date
on February 28, 2025, Ernie L. Danner, Curtis F. Harrell and Andrew L. Waite resigned as directors, effective as of the end of such date
Mr. Kurtenbach will no longer serve as Chairman of the Board and Andrew Siegel, who currently serves as Lead Independent Director of the Board, has been appointed to fill the role of independent Chair of the Board, effective as of the close of business March 5, 2025.
Reece Kurtenbach will cease to serve as the President and Chief Executive Officer of the Company.
On February 28, 2025, Renmei Ouyang, the Chief Executive Officer, President and Chairwoman of the board of directors (the “ Board ”) of BAIYU Holdings, Inc. (the “ Company ”), notified the Company of her decision to resign as the Chief Executive Officer, President, and a director of the Board of the Company.
Mr. Bouvat-Merlin’s employment with the Company terminated February 19, 2025.
On March 3, 2025, Jordan R. Fasbender, the Executive Vice President, Chief Legal Officer and Secretary of iHeartMedia, Inc. (the “Company”) resigned from her positions with the Company, effective on or around April 1, 2025 (the “Effective Date”), to accept another position outside of the Company.
On February 28, 2025, Emil Michael, a member of the Board of Directors (the “Board”) of Rent the Runway, Inc. (the “Company”), tendered his resignation from the Board and all committees on which he served, in each case, effective as of March 1, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.